Group 1: Guizhou Moutai - Guizhou Moutai reported a net profit of 646.27 billion yuan for the first three quarters of 2025, an increase of 6.25% year-on-year [1][2] - The company's revenue for the first three quarters reached 1,284.54 billion yuan, reflecting a growth of 6.36% compared to the previous year [1][2] Group 2: Midea Group - Midea Group achieved a net profit of 378.83 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 19.51% [3][4] - The company's revenue for the same period was 3,630.57 billion yuan, up 13.82% year-on-year [3][4] Group 3: Mindray Medical - Mindray Medical reported a net profit of 75.7 billion yuan for the first three quarters of 2025, a decline of 28.83% year-on-year [5][6] - The company's revenue for the first three quarters was 258.34 billion yuan, down 12.38% compared to the previous year [5][6] Group 4: SanHuan Group - SanHuan Group's net profit for the first three quarters of 2025 was 19.59 billion yuan, reflecting a growth of 22.16% year-on-year [7][8] - The company's revenue for the same period reached 65.08 billion yuan, an increase of 20.96% year-on-year [7][8] Group 5: Longyuan Power - Longyuan Power reported a net profit of 43.93 billion yuan for the first three quarters of 2025, a decrease of 21.02% year-on-year [9][10] - The company's revenue for the same period was 222.21 billion yuan, down 17.29% compared to the previous year [9][10] Group 6: China Nuclear Power - China Nuclear Power's net profit for the first three quarters of 2025 was 80.02 billion yuan, a decline of 10.42% year-on-year [12][13] - The company's revenue for the same period reached 616.35 billion yuan, an increase of 8.16% year-on-year [12][13] Group 7: Fenjie Media - Fenjie Media reported a net profit of 42.40 billion yuan for the first three quarters of 2025, an increase of 6.87% year-on-year [14][15] - The company's revenue for the same period was 96.07 billion yuan, reflecting a growth of 3.73% year-on-year [14][15] Group 8: Tianfu Communication - Tianfu Communication achieved a net profit of 14.65 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 50.07% [17][18] - The company's revenue for the same period was 39.18 billion yuan, up 63.63% year-on-year [17][18] Group 9: Lingyi Technology - Lingyi Technology reported a net profit of 19.41 billion yuan for the first three quarters of 2025, reflecting a growth of 37.66% year-on-year [19][20] - The company's revenue for the same period reached 375.90 billion yuan, an increase of 19.25% year-on-year [19][20] Group 10: Rongsheng Petrochemical - Rongsheng Petrochemical's net profit for the first three quarters of 2025 was 8.88 billion yuan, a growth of 1.34% year-on-year [21] - The company's revenue for the same period was 2,278.15 billion yuan, down 7.09% compared to the previous year [21] Group 11: ShenNan Circuit - ShenNan Circuit reported a net profit of 23.26 billion yuan for the first three quarters of 2025, an increase of 56.30% year-on-year [22] - The company's revenue for the same period was 167.54 billion yuan, reflecting a growth of 28.39% year-on-year [22] Group 12: Jiangbolong - Jiangbolong achieved a net profit of 7.13 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 27.95% [23] - The company's revenue for the same period reached 167.34 billion yuan, up 26.12% year-on-year [23] Group 13: New Yisheng - New Yisheng reported a net profit of 63.27 billion yuan for the first three quarters of 2025, reflecting a growth of 284.37% year-on-year [24] - The company's revenue for the same period was 165.05 billion yuan, an increase of 221.70% year-on-year [24] Group 14: China Merchants Bank - China Merchants Bank achieved a net profit of 1,137.72 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 0.52% [25] - The company's revenue for the same period was 2,514.2 billion yuan, down 0.51% compared to the previous year [25] Group 15: Zhongwei Company - Zhongwei Company reported a net profit of 12.11 billion yuan for the first three quarters of 2025, a growth of approximately 32.66% year-on-year [26] - The company's revenue for the same period reached 80.63 billion yuan, an increase of approximately 46.40% year-on-year [26] Group 16: Microchip Biotech - Microchip Biotech's non-public offering was approved, aiming to raise up to 9.5 billion yuan for innovative drug research and development [27] Group 17: Longyuan Power's Fundraising - Longyuan Power plans to raise up to 50 billion yuan through a private placement to invest in renewable energy projects [28] Group 18: North University Pharmaceutical - North University Pharmaceutical's chairman was detained for investigation, but the company's operations remain normal [29] Group 19: Deyang Shares - Deyang Shares reported a net profit of 23.47 billion yuan for the first three quarters of 2025, a growth of 4.79% year-on-year [30] Group 20: Xiechuang Data - Xiechuang Data achieved a net profit of 6.98 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 25.30% [31] Group 21: Zhifei Biological - Zhifei Biological reported a net loss of 12.06 billion yuan for the first three quarters of 2025, primarily due to lower sales and increased provisions [32] Group 22: Softcom Power - Softcom Power achieved a net profit of 9.89 billion yuan for the first three quarters of 2025, reflecting a growth of 30.21% year-on-year [33] Group 23: Magmi Technology - Magmi Technology reported a net profit of 2.13 billion yuan for the first three quarters of 2025, a decline of 48.29% year-on-year [34] Group 24: Huali Group - Huali Group's net profit for the first three quarters of 2025 was 24.35 billion yuan, a decrease of 14.34% year-on-year [35]

Core Viewpoint - Shengmei Shanghai (688082.SH) reported strong financial performance for the first three quarters of 2025, indicating significant growth in both revenue and net profit [1] Financial Performance - The company achieved total operating revenue of 5.146 billion yuan, representing a year-on-year increase of 29.42% [1] - The net profit attributable to shareholders reached 1.266 billion yuan, showing a year-on-year growth of 66.99% [1] - Basic earnings per share were reported at 2.87 yuan [1]

Core Insights - The company reported a revenue of 5.146 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 29.42% [1] - The net profit attributable to shareholders reached 1.266 billion yuan, with a year-on-year increase of 66.99% [1] - The basic earnings per share stood at 2.87 yuan [2] Financial Performance - The company achieved a gross margin of 49.54%, up by 1.07 percentage points year-on-year, and a net margin of 24.59%, which increased by 5.53 percentage points compared to the same period last year [2] - In Q3 2025, the gross margin was 47.48%, showing a year-on-year increase of 0.39 percentage points but a quarter-on-quarter decrease of 3.15 percentage points [2] - The net margin for Q3 was 30.30%, up by 10.27 percentage points year-on-year and 7.36 percentage points quarter-on-quarter [2] Expense Analysis - Total operating expenses for the period were 1.317 billion yuan, an increase of 227 million yuan year-on-year, with an expense ratio of 25.60%, down by 1.82 percentage points from the previous year [2] - Sales expenses grew by 34.51% year-on-year, while management expenses decreased by 7.82% [2] - R&D expenses increased by 27.59%, and financial expenses saw a significant reduction of 136.54% [2] Company Overview - The company, established on May 17, 2005, is located in the China (Shanghai) Free Trade Zone and specializes in the R&D, production, and sales of semiconductor equipment [3] - The main revenue source is from product sales, accounting for 99.72%, with service provision making up 0.28% [3] - The company is classified under the electronic-semiconductor-semiconductor equipment industry and is associated with concepts such as advanced packaging and integrated circuits [3]

国泰海通证券股份有限公司 关于盛美半导体设备（上海）股份有限公司 调整募集资金投资项目拟投入募集资金金额的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 盛美半导体设备（上海）股份有限公司（以下简称"盛美上海"、"公司"或"发 行人"）首次公开发行股票并在科创板上市以及2024年度向特定对象发行股票的 持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第1号——规范运作》等有关规定，对公司调整募集资金投 资项目拟投入募集资金金额的事项进行了核查，具体情况如下： 一、募集资金的基本情况 根据中国证券监督管理委员会核发的《关于同意盛美半导体设备（上海）股 份有限公司向特定对象发行股票注册的批复》（证监许可[2025]1338号），公司于 2025年9月26日向特定对象发行A股38,601,326股（以下简称"本次发行"），每股 的发行价为人民币116.11元，募集资金总额为人民币4,481,999,961.86元，扣除各 项发行费用人民币46,984,264.81元（不含 ...

为规范公司及子公司募集资金的管理、存放和使用，切实保护投资者权益， 公司及子公司盛帷半导体设备（上海）有限公司开设了募集资金专项账户，并与 保荐机构、存放募集资金的各商业银行签署了《募集资金专户存储三方监管协议》 《募集资金专户存储四方监管协议》。募集资金到账后，已全部存放于经公司董 事会批准开设的募集资金专项账户内。 并以募集资金置换的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 盛美半导体设备（上海）股份有限公司（以下简称"盛美上海"、"公司"或"发 行人"）首次公开发行股票并在科创板上市以及2024年度向特定对象发行股票的 持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第1号——规范运作》等有关规定，对公司使用自有资金方 式支付募投项目所需资金并以募集资金置换的事项进行了核查，具体情况如下： 一、募集资金的基本情况 国泰海通证券股份有限公司 关于盛美半导体设备（上海）股份有限公司 使用自有资金方式支付募投项目所需资金 根据中国证券监督管理委员会核发的《关于 ...

国泰海通证券股份有限公司 关于盛美半导体设备（上海）股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 盛美半导体设备（上海）股份有限公司（以下简称"盛美上海"、"公司"或"发 行人"）首次公开发行股票并在科创板上市以及2024年度向特定对象发行股票的 持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第1号——规范运作》等有关规定，对公司使用部分闲置募 集资金进行现金管理的事项进行了核查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会核发的《关于同意盛美半导体设备（上海）股 份有限公司向特定对象发行股票注册的批复》（证监许可[2025]1338号），公司于 2025年9月26日向特定对象发行A股38,601,326股（以下简称"本次发行"），每股 的发行价为人民币116.11元，募集资金总额为人民币4,481,999,961.86元，扣除各 项发行费用人民币46,984,264.81元（不含增值税），实际 ...

您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查询 盛美半导体设备(上海)股份有限公司 募集资金置换专项鉴证报告 信会师报字[2025]第 ZI10819 号 立信会计师事务所(特殊普通合伙) O CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS LLP 募集资金置换专项鉴证报告 信会师报字[2025]第 ZI10819 号 盛美半导体设备(上海)股份有限公司全体股东: 我们接受委托,对后附的盛美半导体设备(上海)股份有限公司 (以下简称"贵公司")编制的截至 2025年9月26 日止《关于以募 集资金置换预先投入募投项目及支付发行费用的自筹资金的专项说 明》(以下简称"专项说明")进行了合理保证的专项鉴证。 一、管理层的责任 贵公司管理层的责任是按照中国证券监督管理委员会《上市公司 募集资金监管规则》、《上海证券交易所科创板上市公司自律监管指引 第1号 -- 规范运作》的相关规定编制专项说明,这种 ...

国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 盛美半导体设备（上海）股份有限公司（以下简称"盛美上海"、"公司"或"发 行人"）首次公开发行股票并在科创板上市以及2024年度向特定对象发行股票的 持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第1号——规范运作》等有关规定，对公司使用募集资金置 换预先投入募投项目及已支付发行费用的自筹资金的事项进行了核查，具体情况 如下： 一、募集资金基本情况 根据中国证券监督管理委员会核发的《关于同意盛美半导体设备（上海）股 份有限公司向特定对象发行股票注册的批复》（证监许可[2025]1338号），公司于 2025年9月26日向特定对象发行A股38,601,326股（以下简称"本次发行"），每股 的发行价为人民币116.11元，募集资金总额为人民币4,481,999,961.86元，扣除各 项发行费用人民币46,984,264.81元（不含增值税），实际募集资金净额为人民币 4,435,015,697.05元。上述募集资金到位情况已经 ...

盛美半导体设备（上海）股份有限公司 独立董事提名人声明与承诺 提名人盛美半导体设备（上海）股份有限公司董事会，现提名陈大同为盛美 半导体设备（上海）股份有限公司第三届董事会独立董事候选人，并已充分了解 被提名人职业、学历、职称、详细的工作经历、全部兼职、有无重大失信等不良 记录等情况。被提名人已书面同意出任盛美半导体设备（上海）股份有限公司第 三届董事会独立董事候选人（参见该独立董事候选人声明）。提名人认为，被提 名人具备独立董事任职资格，与盛美半导体设备（上海）股份有限公司之间不存 在任何影响其独立性的关系，具体声明并承诺如下： 一、被提名人具备上市公司运作的基本知识，熟悉相关法律、行政法规、规 章及其他规范性文件，具有五年以上法律、经济、会计、财务、管理等履行独立 董事职责所必需的工作经验。 被提名人已经参加培训并取得证券交易所认可的相关培训证明材料。 二、被提名人任职资格符合下列法律、行政法规和部门规章的要求： 三、被提名人具备独立性，不属于下列情形： （一）在上市公司或者其附属企业任职的人员及其直系亲属和主要社会关系 （直系亲属是指配偶、父母、子女等；主要社会关系是指兄弟姐妹、兄弟姐妹的 配偶、配偶的 ...

证券代码：688082 证券简称：盛美上海 公告编号：2025-078 为规范公司及子公司募集资金的管理、存放和使用，切实保护投资者权益， 公司及子公司盛帷半导体设备（上海）有限公司开设了募集资金专项账户，并与 保荐机构、存放募集资金的各商业银行签署了《募集资金专户存储三方监管协议》 《募集资金专户存储四方监管协议》。募集资金到账后，已全部存放于经公司董 事会批准开设的募集资金专项账户内。 二、募集资金投资项目情况 根据《盛美半导体设备（上海）股份有限公司2024年度向特定对象发行A股 股票募集说明书》以及《关于调整募集资金投资项目拟投入募集资金金额的公告》 （公告编号：2025-075）的相关内容，本次发行募集资金扣除各项发行费用后， 将用于投入以下项目： 单位：万元 | 序号 | 募投项目名称 | 拟投资总额 | 调整前拟使用募 集资金投资金额 | 调整后拟使用募 集资金投资金额 | | --- | --- | --- | --- | --- | | 1 | 研发和工艺测试平台建设项目 | 94,034.85 | 92,234.85 | 92,234.85 | | 2 | 高端半导体设备迭代研发项目 | ...